Peptide Plug

Age Verification

Peptide Plug is a research and organization tool intended for adults 18 years of age or older. By continuing, you confirm you are at least 18.

Reference only · Not medical advice · For adults 18+ · No dosing information is published here
Peptide Plug
Healing & Recovery

Kpv — reference

A tripeptide fragment of alpha-MSH studied in animals for anti-inflammatory effects, particularly in the gut.

Regulatory statusNot FDA-Approved
Published half-lifeNot well characterized; short, likely minutes given its small tripeptide structure
Evidence levelNot characterised
CategoryHealing & Recovery

Regulatory status

Not FDA-Approved. Not FDA-approved. Evidence is preclinical.

Reported cautions

⚠ Worth knowing. Carries alpha-MSH's anti-inflammatory signalling without its pigmentation effects, which is the rationale for using the fragment. Human data is essentially absent.

Pharmacokinetics

Published figures give an elimination half-life of Not well characterized; short, likely minutes given its small tripeptide structure. Very limited human data of any kind.

This figure is tagged Not characterised in our evidence system. No reliable human pharmacokinetic data was found for this compound. We publish that fact rather than a number borrowed from an unreliable source. Any estimated curve here would be fiction, and should be treated as such. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.

Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →

What Peptide Plug does and does not publish

This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.

Frequently asked

Is Kpv FDA-approved?
Not FDA-Approved. Not FDA-approved. Evidence is preclinical.
What is the half-life of Kpv?
Published figures give Not well characterized; short, likely minutes given its small tripeptide structure. Very limited human data of any kind.
How reliable is that half-life figure?
It is tagged “Not characterised” in our system. No reliable human pharmacokinetic data was found for this compound. We publish that fact rather than a number borrowed from an unreliable source. Any estimated curve here would be fiction, and should be treated as such.
What cautions are associated with Kpv?
Carries alpha-MSH's anti-inflammatory signalling without its pigmentation effects, which is the rationale for using the fragment. Human data is essentially absent.
Does Peptide Plug publish dosing for Kpv?
No. This library publishes regulatory status, general context and pharmacokinetics only. Dose, frequency and cycle information is deliberately absent from these public pages — those are clinical decisions, not reference data.
Does Peptide Plug sell Kpv?
No. We do not sell, supply, source or link to vendors for any compound, and we have no affiliate arrangements with suppliers. Peptide Plug is a tracking and calculation tool.

Related tools

Free, no account required.

Reference information, not medical advice. This page describes regulatory status and published pharmacokinetics. It does not tell you whether to use this compound, how much to use, how often, or whether it is safe for you. Peptide Plug does not sell, supply or source any compound. Those decisions belong to you and a licensed clinician.